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Distinct subsets of human receptors for alphaherpesviruses mediate the entry of herpes simplex virus (HSV), pseudorabies
virus (PrV), or bovine herpes virus type 1 (BHV-1) into cells. Glycoprotein D (gD) is essential for receptor-mediated entry of
all three viruses into cells. However, the gD homologs of these viruses share only 22–33% amino acid identity. Several entry
receptors for HSV have been identified. Two of these, HveA (HVEM) and HveC (nectin-1), mediate entry of most HSV-1 and
HSV-2 strains and are bound directly by HSV gD. A third receptor, HveB (nectin-2), mediates entry of HSV-2 and only a limited
number of HSV-1 strains. HveB and HveC can also serve as entry receptors for PrV, whereas only HveC can serve this
function for BHV-1. We show here that gD from PrV and BHV-1 binds directly to the human receptors that mediate PrV and
BHV-1 entry. We expressed soluble forms of PrV gD and BHV-1 gD using recombinant baculoviruses and purified each
protein. Using ELISA, we detected direct binding of PrV gD to HveB and HveC and direct binding of BHV-1 gD to HveC.
Biosensor analysis revealed that PrV gD had a 10-fold higher affinity than HSV-1 gD for human HveC. In contrast, the binding
of BHV-1 gD to HveC was weak. PrV gD and HSV-1 gD competed for binding to the V domain of HveC and both inhibited entry
of the homologous and heterologous viruses. These data suggest that the two forms of gD bind to a common region on
human HveC despite their low amino acid similarity. Based on affinities for human HveC, we predict a porcine HveC homolog
may be important for PrV infection in its natural host, whereas a BHV-1 infection in its natural host may be mediated by a
receptor other than a bovine HveC homolog. © 2001 Academic Press
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Herpes simplex virus (HSV), pseudorabies virus (PrV),
and bovine herpes virus (BHV) are highly related alpha-
herpesviruses. In their natural hosts, HSV, PrV, and BHV
typically cause lesions on mucosa and spread to the
peripheral nervous system to establish latent infections
in neurons. The viruses encode homologs of several
membrane glycoproteins and at least four of these (gD,
gH, gL, and gB) are essential for entry of virions into
cells. The current model for virus entry involves a series
of events. First gC and/or gB bind cell surface heparan
sulfate proteoglycans. This is followed by the binding of
gD to one of several cell surface receptors. The binding
of gD to receptor is a critical step of viral entry that leads
to membrane fusion facilitated by gD, gH, gL, and gB
(see reviews in Enquist et al., 1998; Spear, 1993; Spear et
l., 2000; Tikoo et al., 1995).
Several cellular receptors for HSV have been identified
1 To whom correspondence and reprint requests should be ad-
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53, Mail Code 6002, Philadelphia, PA 19104. Fax: (215) 898-8385.
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7through expression cloning and homology searches.
Though initially identified as receptors for HSV, subsets
of these receptors also mediate entry of PrV and BHV-1.
Herpes virus entry mediator A (HveA or HVEM), a mem-
ber of the tumor necrosis factor receptor family, can
mediate entry of most HSV-1 and HSV-2 strains (Mont-
gomery et al., 1996). HveB, a member of the immuno-
globulin (Ig) superfamily, can mediate entry of HSV-2, PrV,
and some laboratory strains of HSV-1 (ANG, Rid) (Lopez
et al., 2000; Warner et al., 1998). HveC, also a member of
the Ig superfamily, can mediate entry of HSV-1, HSV-2,
PrV, and BHV-1 (Cocchi et al., 1998b; Geraghty et al.,
1998). HveB and HveC appear to be involved in cell–cell
adhesion interactions and have been named nectin-2
and nectin-1, respectively (Aoki et al., 1997; Lopez et al.,
1998; Takahashi et al., 1999).
Expression of gD is limited to the alphaherpesvirus
subfamily of herpesviruses and most alphaherpesvi-
ruses express gD. Though the function of gD in HSV-1,
PrV, and BHV-1 entry appears similar, the three forms of
gD share less than 33% amino acid identity. This se-
quence variability may contribute to differences in gD
usage among the three viruses. Although gD is critical
for entry of all three viruses, gD is required for direct
cell-to-cell spread of HSV and BHV-1, but not PrV (Fehler
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Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
g
d
e
8 CONNOLLY ET AL.et al., 1992; Ligas and Johnson, 1988; Rauh and Metten-
leiter, 1991). Additionally, a gD-null BHV-1 that carries a
gH mutation can overcome the need for gD to spread
(Schro¨der et al., 1997). In fact, mutants of both BHV-1 and
PrV have been selected that overcome the need for gD
entirely (Schmidt et al., 1997; Schro¨der et al., 1997).
Previous studies showed that expression of HSV, PrV,
or BHV-1 gD inhibits the entry of both homologous and
heterologous viruses, presumably because the ex-
pressed gD interacts with receptor(s) on the cell to in-
hibit productive interaction of the receptor with virus
(Campadelli-Fiume et al., 1988; Chase et al., 1990, 1993;
Johnson and Spear, 1989; Petrovskis et al., 1988; Tikoo et
al., 1990). However, this gD-mediated interference is not
always reciprocal. For example, bovine cells expressing
BHV-1 gD were resistant to PrV infection, while cells
expressing PrV gD were not resistant to BHV-1 (Chase et
al., 1990, 1993). This nonreciprocity may result from the
use of different subsets of receptors by the viruses.
Recently this issue was reexamined using Chinese ham-
ster ovary (CHO) cells engineered to coexpress human
HveC and one of the three gD molecules (Geraghty et al.,
2000). On these cells, HSV-1, PrV, and BHV-1 gD-medi-
ated interference was reciprocal. All three gD molecules
were shown to associate with HveC and inhibit entry of
all three viruses. However, the extent of interference
differed among the three forms of gD, which may reflect
differences in affinity of the three forms of gD for HveC.
Soluble forms of HSV gD can also inhibit virus entry
into cells, presumably by competing with virion gD for
interaction with receptor(s) (Johnson et al., 1990). Trun-
cated soluble forms of HSV gD were previously shown to
bind directly to receptors (Cocchi et al., 1998a; Krummen-
acher et al., 1998; Whitbeck et al., 1997). The binding of
D from different HSV strains to either HveA or HveC
irectly correlates with the ability of those HSV strains to
nter cells via the receptors (Geraghty et al., 1998; Mont-
gomery et al., 1996). The goal of this study was to deter-
mine whether PrV gD and BHV-1 gD bind directly to
receptors capable of mediating PrV and BHV-1 entry.
Furthermore, we wanted to determine whether HSV-1
gD, PrV gD, and BHV-1 gD bind common receptors with
different affinities. We found a correlation between the
ability of HveA, HveB, and HveC to mediate entry of the
viruses and the binding of the respective gD molecules
to the receptors. We also found that PrV gD and HSV-1
gD bind to similar regions on HveC, but PrV gD binds
with a higher affinity, causing it to compete better for
HveC binding both in solution and on the cell surface.
RESULTS
Production and characterization of soluble gD
proteins
We expressed and purified truncated soluble forms of
PrV gD and BHV-1 gD using a baculovirus expressionsystem (Fig. 1) (Sisk et al., 1994; Willis et al., 1998a). PrV
gDt and BHV-1 gDt migrate as single bands by SDS–
PAGE as judged by silver staining (Fig. 2A). Both PrV gDt
and BHV-1 gDt were resistant to digestion by endogly-
cosidase H. BHV-1 gDt was endoglycosidase F sensitive,
while PrV gDt was not (Fig. 2C). This indicates that BHV-1
gDt contains complex N-linked glycosylations, whereas
PrV gDt contains no N-linked oligosaccharides, as pre-
dicted from the DNA sequences (Petrovskis et al., 1986;
van Drunen Littel-van den Hurk and Babiuk, 1985). Mass
spectroscopy of the PrV gDt and BHV-1 gDt proteins
reveals molecular masses of 40.7 and 41.5 kDa, respec-
tively (Fig. 2B).
Detection of PrV gDt and BHV-1 gDt with MAbs
Prior to testing receptor binding activity, we used
MAbs to determine whether the soluble proteins were
antigenically correct. Native or denatured PrV gDt or
BHV-1 gDt were immobilized on nitrocellulose and
probed with various MAbs (see Materials and Methods
for MAb sources). PrV gDt reacted with two MAbs that
recognized linear epitopes (6D8MB4, 87W001) and two
MAbs that required native conformation for maximum
reactivity (S4B1.1C11, 22M24). BHV-1 gDt reacted with
four MAbs that recognized linear epitopes (9D6, 3D9S,
3402, 1B8-F11) and 15 MAbs that required native confor-
mation for maximum reactivity (136, 3E7, 10C2, 4C1, 2C8,
3C1, 722, 1106, 2704, 4603, 5006, 1102, 1004, 4906, 2H6-
C2) (data not shown).
FIG. 1. Schematic representation of gD homologs. Full-length and
truncated (t) forms of HSV-1 gD, PrV gD, and BHV-1 gD are depicted as
solid lines. HSV-1 gD amino acids are numbered from the N-terminus
of the mature gD after signal peptide cleavage. PrV gD and BHV-1 gD
amino acids are numbered from the initial methionine. Open boxes
represent the natural signal sequences. Gray boxes represent the
mellitin signal peptide used in the baculovirus constructs. Cysteine
residues are depicted as C’s and disulfide bonds are indicated by
dotted lines. Lollypop structures represent consensus N-glycosylation
sites. Amino acid changes resulting from cloning are defined. Trun-
cated proteins are tagged with a six-histidine tail (H6) after truncation
at the indicated amino acid, prior to the transmembrane region (TM).
Previous studies refer to this HSV-1 gDt as gD-1(306t).In addition, we immunoprecipitated HSV-1, PrV, and
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linear epitopes (Fig. 2D). By adding increasing amounts
of ascites fluid, we determined the maximum amount of
gDt that could be immunoprecipitated using MAbs spe-
cific for linear epitopes (DL6, 6D8MB4, 1B8-F11). The
amount of gDt immunoprecipitated by MAbs that recog-
nize conformational epitopes (DL2, S4B1.1C11, 2H6-C2)
was at least as great as the maximum amount immuno-
precipitated by MAbs specific for linear epitopes. Thus,
we conclude that the MAbs recognizing conformational
epitopes immunoprecipitate at least as much gDt from
our preparations as the MAbs specific for linear
epitopes. Though the affinity of each MAb for gDt affects
these results, the high efficiency of gDt immunoprecipi-
tation using MAbs that recognize conformational
epitopes increases our confidence that a large portion of
FIG. 2. Purified soluble PrV gDt and BHV-1 gDt. (A) HSV-1 gDt, PrV
gDt, and BHV-1 gDt were purified from recombinant baculovirus-in-
fected Sf9 cell supernatants, electrophoresed on denaturing SDS–10%
polyacrylamide gels, and visualized by silver stain. Molecular mass
markers are indicated. (B) Mass spectrometric analysis of PrV gDt and
BHV-1 gDt was performed. Masses at peaks are indicated in kilodal-
tons (kDa). (C) PrV gDt and BHV-1 gDt were denatured; incubated
overnight at 37°C with endoglycosidase H (lanes H), endoglycosidase
F (lanes F), or no enzyme (lanes –); electrophoresed on denaturing
SDS–10% polyacrylamide gels; and visualized by Western blot probed
with anti-tetra-His MAb. Molecular mass markers are indicated. (D)
HSV-1 gDt, PrV gDt, or BHV-1 gDt was immunoprecipitated using 8 mL
of the indicated MAb, electrophoresed on denaturing SDS–10% poly-
acrylamide gels, and visualized by Western blots using PAb R7, R170, or
EnvA. MAbs DL2, S4B1.1C11, and 2H6-C2 recognize conformational
epitopes, while MAbs DL6, 6D8MB4, and 1B8-F11 recognize linear
epitopes.the protein in our preparations is correctly folded.Binding of PrV gDt and BHV-1 gDt to receptors
by ELISA
We previously used ELISA to show that HSV-1 gDt
binds directly and specifically to human HveA and HveC
(Krummenacher et al., 1998; Whitbeck et al., 1997). Here
we used ELISA to determine whether PrV gDt and BHV-1
gDt bind directly to HveA, HveB, or HveC. Purified HveAt,
HveBt, or HveCt (Krummenacher et al., 1998; Warner et
al., 1998; Whitbeck et al., 1997) were immobilized on an
LISA plate and increasing concentrations of PrV gDt,
HV-1 gDt, or HSV-1 gDt were added. Bound gDt was
hen detected using antibodies. As expected, HSV-1 gDt
ound to HveAt and HveCt in a dose-dependent fashion
ut did not bind HveBt (Fig. 3A). PrV gDt bound to HveCt
nd HveBt, but not to HveAt (Fig. 3B). BHV-1 gDt bound to
veCt, only weakly to HveBt, and not to HveAt (Fig. 3C).
y comparing the binding of BHV-1 gDt and HSV-1 gCt to
veCt, we demonstrate that the binding of BHV-1 gDt to
veCt is specific (Fig. 3D). Thus, the ability of these
FIG. 3. Binding of gDt homologs to three HSV receptors. ELISA plates
were coated with HveAt, HveBt, or HveCt. Increasing concentrations of
HSV-1 gDt, PrV gDt, BHV-1 gDt, or HSV-1 gCt were added and binding
was detected using specific antibodies. Absorbance at 405 nm (A405)
was recorded after the addition of HRP-conjugated secondary Ab
followed by substrate. (A) HSV-1 gDt was detected using rabbit anti-
serum R7. (B) PrV gDt was detected using a mixture of MAbs S4B1.
1C11 and 6D8MB4. (C) BHV-1 gDt was detected using a mixture of
MAbs 3D9S, 4906, 3402, 10C2, and 9D6. (D) BHV-1 gDt and HSV-1 gCt
binding to HveCt was detected using rabbit antisera PAb specific for
tgD (BHV-1 gDt) or R47 (HSV-1 gCt).
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10 CONNOLLY ET AL.receptors to mediate viral entry correlates with the ability
of the receptors to bind the corresponding viral gD.
By comparing the positions of curves and the gDt
concentrations required to reach half-saturating levels of
binding, we conclude that PrV gDt dinds HveCt with the
highest affinity, followed by HSV-1 gDt and then BHV-1
gDt. Half-saturation of HveCt binding was reached at
0.08 mM PrV gDt and 0.6 mM HSV-1 gDt. Saturation of
inding was not reached for BHV-1 gDt. PrV gDt also
inds HveBt better than does BHV-1 gDt, although both
Dt molecules bind HveBt less well than HveCt. To more
ccurately compare the binding affinities of the three gD
roteins for HveC, we employed optical biosensor anal-
sis.
veC binding affinity constants
Biosensor analysis was previously used to measure
he affinity of HSV-1 gDt for HveAt and HveCt (Krummen-
cher et al., 1999; Whitbeck et al., 1999; Willis et al.,
998b). Here we examined the binding affinities of PrV
Dt and BHV-1 gDt for HveCt. Serial dilutions of HSV-1
Dt, PrV gDt, BHV-1 gDt, and HSV-1 gCt were flowed over
veCt immobilized on a chip and real-time binding was
ecorded (Fig. 4). HSV-1 gDt binding data were previously
it to a 1:1 binding model (Krummenacher et al., 1999).
rV gDt binding data were fit to the same model.
FIG. 4. Real-time analysis of gDt homologs binding HveCt. HveCt
was immobilized on a CM5 chip in a BIAcore X instrument. The
indicated concentrations of HSV-1 gDt, PrV gDt, BHV-1 gDt, and HSV-1
gCt were flowed over the chip for 2 min (association). Buffer alone was
then flowed over the chip for 2 min (dissociation). The sensorgrams
shown represent raw data with signals from a blank control flow cell
and signals from injections of buffer alone subtracted out. Data points
were collected at 5 Hz and the data were analyzed using BIAevaluation
3.0 software. (A) HSV-1 gDt binding HveCt (Krummenacher et al., 1999).
(B) PrV gDt binding HveCt. For clarity in (A) and (B), one of every 25
collected data points is represented by a symbol. The solid lines
represent the best fit of the data using global fitting. (C) BHV-1 gDt
binding HveCt. (D) HSV-1 gCt binding HveCt. In (C) and (D), the solid
lines represent the collected data. No fit is depicted.Kinetic rates and affinity constants for the HSV-1 gDtnd PrV gDt are summarized in Table 1. Data for HSV-1
Dt binding to HveCt were previously reported (Whitbeck
t al., 1999) and are included for comparison. PrV gDt
ad a 10-fold higher affinity for HveC than did HSV-1 gDt
nd this higher affinity was mainly the result of an in-
reased on rate (kon) of binding.
High concentrations of BHV-1 gDt were required to
observe binding to HveCt on the chip (Fig. 4). For exam-
ple, a binding signal of 70 resonance units (RU) required
16 mM BHV-1 gDt, but only 0.063 mM PrV gDt. Comparing
qual concentrations of BHV-1 gDt and HSV-1 gCt bind-
ng to HveCt demonstrates that the binding of BHV-1 gDt
o HveCt is specific. Smooth association and dissocia-
ion curves are seen with BHV-1 gDt and not with HSV-1
Ct. The HSV-1 gCt signals represent background
hanges in refractive index as a result of the high con-
entrations of protein used.
We were unable to calculate an affinity constant for
HV-1 gDt binding to HveCt because the data did not fit
ny model provided in the BIAevaluation software pack-
ge. However, the shape of the binding curves suggests
hat BHV-1 gDt binds HveCt, but rapidly dissociates (fast
ff-rate). Thus, the weak binding is apparently the result
f poor stability of the complex. We calculated the max-
mum off-rate for BHV-1 gDt at 34 3 1022 s21 (Rux et al.,
1998). We conclude from the biosensor and ELISA data
that BHV-1 gDt has a significantly lower affinity for HveCt
than does either HSV-1 gDt or PrV gDt. For this reason,
we limited the following studies to the interaction be-
tween PrV gD and HveC.
Localization of PrV gDt binding site to HveC V domain
We previously showed that HSV-1 gDt binds directly to
a soluble form of HveC containing only the immunoglob-
ulin V domain, called HveC(143t) (Krummenacher et al.,
1999). To determine whether PrV gDt also binds to the V
domain, HveC(143t) was immobilized on an ELISA plate
and increasing concentrations of PrV gDt were added.
Binding to HveC(143t) was observed, although high con-
centrations of PrV gDt were required (Fig. 5A).
Previous studies showed that recognition of
TABLE 1
Kinetic and Affinity Values for gDt/HveCt Complex Formation
kon
(103 M21 s21)
(on rate)
koff
(1022 s21)
(off rate)
KD
(1026 M)a
(affinity)
HSV-1 gDtb 2.6 6 0.7c 0.71 6 0.09c 2.7 6 0.2
PrV gDt 98 6 5c 1.3 6 0.1c 0.13 6 0.07
a KD 5 koff/kon.
b Values for HSV-1 gDt were reported previously (Whitbeck et al.,1999) and are included here for comparison.
c Average 6 SD from at least three experiments.
P11AFFINITIES OF gD HOMOLOGS FOR HveC (NECTIN-1)HveC(143t) by a conformational MAb is reduced when
HveC(143t) is immobilized on an ELISA plate (Krummen-
acher et al., 1999). To compare the binding of PrV gDt to
HveCt and HveC(143t), we used a competition assay that
measures the binding of PrV gDt and HveCt in solution.
ELISA plates coated with HveCt were incubated with a
mixture of PrV gDt and increasing concentrations of
either HveC(143t) or HveCt. PrV gDt binding to the im-
mobilized HveCt was then measured. The amount of
binding in the absence of soluble competitor was de-
fined as 100% binding. Soluble HveCt and HveC(143t)
inhibited the binding of PrV gDt to the immobilized HveCt
equally well (Fig. 5B), indicating that PrV gDt binds to the
V domain of HveC as efficiently as it does to the full
ectodomain of HveC.
Competition between HSV-1 and PrV gDt for HveC
binding
Considering that both HSV-1 gDt and PrV gDt bind to
the HveC V domain (Cocchi et al., 1998a; Krummenacher
et al., 1999), we determined whether the two gD proteins
could compete for HveCt binding. HveCt was immobi-
lized on an ELISA plate and mixtures of the two gD
proteins were added in solution. We determined whether
increasing the concentration of one gDt affected the
binding of the second gDt held at a constant concentra-
tion. The amount of binding in the absence of soluble
competitor was defined as 100% binding. As the concen-
tration of PrV gDt increased, the binding of HSV-1 gDt
decreased (Fig. 6A). Likewise, as the concentration of
HSV-1 gDt increased, the binding of PrV gDt decreased
(Fig. 6B). We conclude that PrV gDt and HSV-1 gDt
compete with each other for HveCt binding.
HSV-1 gDt binding was inhibited by 50% at 0.55 mM
rV gDt and PrV gDt binding was inhibited by 50% at 3.5
FIG. 5. PrV gDt binding to the V domain of HveC. (A) ELISA plates
were coated with HveC(143t) and incubated with increasing concen-
trations of PrV gDt. Bound PrV gDt was detected using a mixture of
MAbs S4B1.1C11 and 6D8MB4. (B) ELISA plates were coated with
HveCt and incubated with a constant concentration of PrV gDt and
increasing concentrations of either HveCt or HveC(143t) (as soluble
competitors). PrV gDt bound to immobilized HveCt was detected with a
mixture of MAbs S4B1.1C11 and 6D8MB4. Results are expressed as a
percentage of gD binding in the absence of soluble competitor (100%).mM HSV-1 gDt. This observation agrees with the previ-ous data indicating that PrV gDt has a higher affinity for
HveCt than does HSV-1 gDt.
Inhibiting infection of HveC-expressing cells with
soluble gDt
Previous reports showed that soluble HSV gD can
inhibit HSV entry, presumably by competing with virion
gD for interaction with receptor (Fuller and Lee, 1992;
Johnson et al., 1990; Nicola et al., 1997; Tal-Singer et al.,
1995). We used this type of inhibition of entry to examine
how HSV-1 gDt and PrV gDt compete with virion gD to
bind to HveC on a cell surface. Since HSV-1 gDt and PrV
gDt compete to bind to HveCt, both forms of gDt should
inhibit entry of both HSV-1 and PrV into HveC-expressing
cells. Furthermore, if the two gD molecules differ in
affinity for full-length HveC on the cell surface, PrV gDt
should inhibit virus entry more efficiently than does
HSV-1 gDt. To test this, M3A cells, which are derived
from nonpermissive CHO cells and express human
HveC, were incubated with HSV-1 gDt or PrV gDt prior to
the addition of HSV-1 hrR3 or PrV BeBlu, virus strains
carrying lacZ (Banfield et al., 1998; Goldstein and Weller,
1988). The amount of entry in the absence of soluble
protein was defined as 100% entry.
Entry of HSV-1 and PrV into M3A cells was efficiently
inhibited by both gDt proteins (Fig. 7). The inhibition of
both homologous and heterologous virus entry by HSV-1
gDt and PrV gDt agrees with the competition ELISA
results. Moreover, PrV gDt was more efficient than HSV-1
FIG. 6. Competition between PrV gDt and HSV-1 gDt for HveC
binding. ELISA plates were coated with HveCt and incubated with
mixtures of HSV-1 gDt and PrV gDt. Results are expressed as a
percentage of binding in the absence of soluble competitor (100%). (A)
HSV-1 gDt (0.5 mM) and increasing concentrations of PrV gDt (as
competitor) were added to the plate. Bound HSV-1 gDt was detected
with MAb DL2. (B) PrV gDt (0.5 mM) and increasing concentrations of
HSV-1 gDt (as competitor) were added to the plate. Bound PrV gDt was
detected with MAb 6D8MB4.
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12 CONNOLLY ET AL.gDt at inhibiting entry of both viruses. The concentrations
required to inhibit 40% of both HSV-1 and PrV entry were
2 mM HSV-1 gDt and 0.25 mM PrV gDt. These results
correlate with affinity differences measured using solu-
ble HveCt. We conclude that the higher affinity of PrV gDt
for HveC is evident both when HveC is on the cell
surface and in a truncated soluble form.
Inhibiting PrV entry into porcine cells with PrV gDt
Since the preceding virus entry studies examined the
interaction between PrV gD and a human receptor, we
also tested the ability of PrV gDt to inhibit entry into
porcine cells (Fig. 8). Porcine kidney (PK15) cells were
incubated with increasing concentrations of PrV gDt and
then infected with PrV BeBlu. PrV gDt effectively inhibited
the entry of PrV. We conclude that soluble PrV gDt is able
to inhibit PrV entry, presumably by interacting with a
porcine entry receptor(s) and competing with viral gD for
binding.
DISCUSSION
Previous studies showed that human HveC can medi-
ate cell entry of HSV-1, PrV, and BHV-1, despite low amino
acid similarity among the gD homologs of these viruses
(Geraghty et al., 1998). This study demonstrates direct
binding of soluble forms of the three gD molecules to
HveC. Furthermore, we detected differences in affinity for
HveC among the three gD molecules.
FIG. 7. Inhibition of HSV-1 and PrV entry with HSV-1 gDt and PrV gDt.
M3A cells expressing HveC were incubated with gDt or BSA at 4°C for
90 min. Virus encoding lacZ was added and after 90 min, the cells were
hifted to 37°C. After 5 h, the cells were lysed and b-gal activity was
measured as an indication of virus entry. Signals from duplicate wells
were averaged for each concentration and expressed as a percentage
of signal in the absence of soluble protein (100%). (A) Inhibition of
HSV-1 entry. (B) Inhibition of PrV entry.Using a baculovirus expression system, we produced
e
(purified soluble forms of three gD homologs that retained
receptor-binding capacity. Previously other gD homologs
were also successfully expressed using baculovirus, in-
cluding that of HSV, BHV-1, and equine herpesvirus
(Flowers et al., 1995; Sisk et al., 1994; van Drunen Littel-
van den Hurk et al., 1991).
Direct binding of gD to receptors
Our ELISA binding data correlate with the known cell
receptor usage for HSV-1, PrV, and BHV-1 (Geraghty et al.,
1998; Montgomery et al., 1996; Warner et al., 1998). Spe-
cifically, HveA mediates entry of only HSV and binds only
HSV gDt. In contrast, HveC mediates entry of all three
viruses and binds all three forms of gDt.
HveB was reported to mediate entry of only PrV, but it
binds both PrV gDt and BHV-1 gDt. However, BHV-1 gDt
binding is weak and requires high concentrations. This
low level of binding may be insufficient to mediate entry.
Both PrV gDt and BHV-1 gDt bind HveBt less well than
HveCt. This lower binding capacity of HveB was also
shown with an HSV-1 gD mutant protein that is able to
bind both HveB and HveC (Lopez et al., 2000).
The ELISA data suggest the affinity for HveCt is high-
est with PrV gDt, followed by HSV-1 gDt, and then with
BHV-1 gDt. Biosensor data show that the high affinity of
PrV gDt for HveCt is primarily because of a faster on-rate.
The affinity of PrV gDt for HveC is 10-fold higher than the
affinity of HSV-1 gDt for HveC. The off-rates for PrV gDt
and HSV-1 gDt are similar, indicating that the stability of
the gD/HveC complex is similar for both PrV gDt and
HSV-1 gDt. The affinity of PrV gDt for HveC is comparable
to that of gD(rid1t), a previously characterized HSV-1 gD
mutant protein which carries a mutation at position 27
(Dean et al., 1994; Krummenacher et al., 1999).
We were unable to calculate a KD for BHV-1 gDt bind-
ing HveCt; however, we estimate the affinity is at least
10-fold lower than that of HSV-1 gD (2.7 3 1026 M) based
n both ELISA and biosensor results. Biosensor data
FIG. 8. Inhibition of PrV entry with PrV gDt. PK15 cells were incubated
with PrV gDt or BSA at 4°C for 90 min. PrV encoding lacZ was added
nd after 90 min, the cells were shifted to 37°C. After 5 h, the cells were
ysed and b-gal activity was measured as an indication of PrV entry.
ignals from duplicate wells were averaged for each concentration and
xpressed as a percentage of signal in the absence of soluble protein
100%).
H13AFFINITIES OF gD HOMOLOGS FOR HveC (NECTIN-1)show a fast off-rate, suggesting that the BHV-1 gD/HveC
complex is unstable. Similar biosensor data were ob-
tained previously with an HSV-1 gD C-terminal truncation
mutant called HSV gD(234t), which binds HveAt but dis-
sociates rapidly (Rux et al., 1998).
Assuming our in vitro results reflect the situation in
vivo, these differences in affinity for HveC may explain
why expression of different forms of gD confers different
degrees of resistance to infection. The low affinity of
BHV-1 gDt for HveC likely explains why expression of
BHV-1 gD in HveC-expressing CHO cells inhibits viral
entry less efficiently than expression of either HSV-1 gD
or PrV gD (Geraghty et al., 2000). Although expression of
PrV gD in that study did not produce much higher levels
of inhibition than those of HSV-1 gD, a previous study
showed HeLa cells expressing PrV gD are more resis-
tant to HSV than to PrV (Petrovskis et al., 1988). Since
HeLa cells express HveC (Cocchi et al., 1998b), the high
affinity of PrV gD for HveC may explain this greater
resistance to infection by HSV than by Prv.
PrV gD and HSV-1 gD competition for HveC binding
PrV gDt binds to the V domain of HveC as efficiently as
it does to the full ectodomain of HveC. This shows that
PrV gDt and HSV-1 gDt bind to the same domain on
HveC. Moreover, PrV gDt and HSV-1 gDt compete with
each other to bind HveC by ELISA, suggesting that the
two gD molecules bind the same physical structure on
the V domain of HveC. Thus, PrV gD may bind to HveC
within a critical HSV-1 gD binding site recently identified
between amino acid residues 80 and 104 (Krummen-
acher et al., 2000).
The binding of both forms of gD to the same region of
HveC implies a common structure between these two
homologs, despite their low amino acid similarity. The
conservation of cysteine spacing may be a key element
of this structure (Fig. 1).
The competition between HSV-1 gD and PrV gD for
HveC binding is also seen when HveC is on the cell
surface and gD is in the virion. HSV-1 gDt and PrV gDt
inhibit entry of both HSV-1 and PrV on HveC-expressing
CHO cells, presumably by competing with virion gD for
binding to HveC on the cell. As in the competition ELISA,
the affinity difference between PrV gDt and HSV-1 gDt is
evident, with PrV gDt inhibiting entry of both HSV-1 and
PrV more efficiently than does HSV-1 gDt.
Competition for HveC binding explains previous re-
sults showing that expression of HSV-1 gD or PrV gD
interferes with infection by the heterologous virus (Ger-
aghty et al., 2000). Competition for HveC binding may
also explain why UV-inactivated PrV added to cells is
able to inhibit HSV-1 entry and vice versa (Lee and Fuller,
1993).HveC homologs
PrV gDt inhibited entry of PrV when added to porcine
cells prior to infection, presumably by competing with
virion gD for binding to porcine cell surface receptor(s).
This type of inhibition was previously shown with soluble
forms of HSV gD and BHV-1 gD (Johnson et al., 1990; Li
et al., 1995).
The porcine receptor(s) involved in PrV entry is un-
known, but a murine HveC homolog with a remarkable
level of conservation with human HveC was recently
identified (Menotti et al., 2000). Perhaps highly con-
served bovine and porcine HveC homologs also exist. If
PrV uses a porcine HveC homolog for entry, PrV gD
binding likely involves the V domain of porcine HveC.
The low affinity and rapid dissociation of BHV-1 gDt
from human HveC shed doubt on the importance of a
bovine HveC homolog for BHV-1 infection. However, the
affinity of BHV-1 gD for bovine HveC may be much higher
than that for human HveC or virion gD avidity for receptor
may affect HveC usage. Previous studies showed that
PrV gD expression in bovine cells did not interfere with
BHV-1 entry, implying that PrV and BHV-1 can use differ-
ent receptors for entry (Chase et al., 1993). The ability of
BHV-1 gD expression to interfere with PrV entry implies
the viruses can also share a receptor (Chase et al., 1990).
These results indicate BHV-1 likely uses multiple recep-
tors for entry into bovine cells.
This study showed that human HveC is functional for
alphaherpesvirus entry into cells, despite a wide range
in affinities of gD for the receptor. Even low-affinity bind-
ing, such as that between BHV gDt and HveCt or PrV gDt
and HveBt, is sufficient to mediate virus entry. The affin-
ities of PrV gD and BHV-1 gD for their native receptors
and the ability of porcine and bovine HveC homologs, if
they exist, to serve as receptors remain to be deter-
mined.
MATERIALS AND METHODS
Cells and viruses
Sf9 (Spodoptera frugiperda) cells (GIBCO BRL, Gaith-
ersburg, MD) were maintained in suspension in Sf900II
medium (GIBCO BRL) or as a monolayer in Grace’s
medium (GIBCO BRL) supplemented with 10% fetal calf
serum (FCS). CHO-IEb8 cells express the b-galactosi-
dase gene under the control of the ICP4 promoter and
were kindly provided by Dr. P. G. Spear. M3A cells were
derived from CHO-IEb8 cells stably transfected with the
gene for HveC under the cytomegalovirus IE promoter
(Krummenacher et al., 1999; Montgomery et al., 1996;
Terry-Allison et al., 1998). CHO-IEb8 cells were grown in
am’s F-12 medium supplemented with 10% FCS and 150
mg/mL puromycin. M3A cells were and grown in Ham’s
F-12 medium supplemented with 10% FCS, 150 mg/mL
puromycin, and 250 mg/mL G418. PK15 cells (American
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14 CONNOLLY ET AL.Type Culture Collection [ATCC], Rockville, MD) were
grown in DMEM (Dulbecco’s minimal essential medium)
supplemented with 5% FCS.
HSV-1 hrR3 carries lacZ under the ICP6 promoter and
was kindly provided by Dr. S. K. Weller (Goldstein and
Weller, 1988). PrV BeBlu carries lacZ under the gG pro-
oter and was kindly provided by Dr. L. W. Enquist
Banfield et al., 1998).
Polyclonal (PAb) and monoclonal (MAb) antibodies
Anti-HSV-1 gD MAb DL2 was raised against full-length
purified HSV-1 gD (Cohen et al., 1986). Rabbit PAb serum
R7 was raised against HSV-2 gD and cross-reacts with
HSV-1 gD (Isola et al., 1989). PrV gD MAbs were kindly
provided by Drs. N. E. Coe (S4B1.1C11) (Coe and Men-
geling, 1990), M. Eloit (22M24) (Eloit et al., 1988), and F. A.
Zuckermann (87W001) (Zuckermann et al., 1988). Rabbit
PAb serum R170 was raised against purified PrV gDt.
BHV-1 gD MAbs were kindly provided by Drs. L. A.
Babiuk and S. van Drunen Littel-van den Hurk (136, 9D6,
3E7, 10C2, 4C1, 2C8, 3C1, 3D9S) (Hughes et al., 1988; van
runen Littel-van den Hurk et al., 1984) and by Dr. G. J.
etchworth (722, 2704, 4603, 5006, 1106, 4906, 1102,
004, 3402) (Marshall et al., 1988). Rabbit PAb serum (PAb
pecific for tgD) was raised against truncated BHV-1 gD
nd was kindly provided by Dr. S. van Drunen Littel-van
en Hurk (Kowalski et al., 1993). EnvA is a rabbit poly-
lonal serum raised against the Nonidet P-40 (NP-40)-
oluble components of gradient-purified BHV-1 virions
nd was a generous gift from L. J. Bello and W. C.
awrence. Hybridoma cell lines for the PrV gD MAb
D8MB4 and BHV-1 gD MAbs 1B8-F11 and 2H6-C2 were
btained from ATCC. Ascites fluids were prepared by
ocalico Biologicals (Backwater, PA). Anti-tetra-His MAb
gG was obtained from Qiagen (Chatsworth, CA). Anti-
veAt MAb CW2 was raised against purified HveAt
Whitbeck et al., 2000).
Construction of recombinant baculoviruses
The strategy used to generate PrV gDt and BHV-1 gDt
was the same as described previously to generate sol-
uble HSV gD-1(306t) (Sisk et al., 1994). As a result of the
loning strategy, the predicted native signal sequences
or PrV gD (residues 1–17) and BHV-1 gD (residues 1–18)
ere replaced with the honeybee mellitin signal se-
uence, the predicted transmembrane and cytoplasmic
egions were removed, and the C-termini were tagged
ith six histidine residues. Plasmid pWW117 (Mug-
eridge et al., 1990) was used as a template for PCR
amplification of PrV gDt (Rice strain). An upstream primer
59-CCGAGATCTGGACGCTGTGCCCGCACCGACCT-39
and a downstream primer 59-GCCGAATTCAATGATGAT-
GGTGATGATGTGAGCGATGGCGCGAGA-39 amplified a
truncated version of PrV gD, including amino acids 19 to
354, with a valine-to-leucine change at residue 20. Plas- amid BHV1HindIIIK (Lawrence et al., 1986) was kindly
provided by Dr. W.C. Lawrence and used as a template
for PCR amplification of BHV-1 gDt (Cooper strain). An
upstream primer 59-GCGGATCCATTGCCTACACCTG-
CACCACGGGTGAC-39 and a downstream primer
59-CGGAATTCAATGATGATGATGATGATGGGCGTCAGG-
GGCTGCGGGCGTA-39 amplified a truncated version of
BHV-1 gD, including amino acids 19 to 360, with an
aspartic acid and proline added at the N-terminus. Using
the underlined restriction digest sites, the PrV gD and
BHV-1 gD fragments were digested and ligated with DNA
from pVT-Bac (Tessier et al., 1991) to generate plasmids
SC322 and pSC323, respectively. DNA from these plas-
ids was recombined into baculovirus by cotransfection
ith Baculogold DNA (PharMingen, San Diego, CA) into
f9 cells. Plaques were picked and screened for protein
xpression via Western blot. Baculovirus recombinants
xpressing gD were subjected to two rounds of plaque
urification. The recombinant baculoviruses were named
ac-PrVgDt and bac-BHV1gDt; the recombinant proteins
ere named PrV gDt and BHV-1 gDt.
roduction and purification of PrV gDt and BHV-1 gDt
PrV gDt and BHV-1 gDt were produced and purified
ssentially as described for HSV gD-1(306t) (Sisk et al.,
994; Willis et al., 1998a). Sf9 cells were grown in sus-
ension, infected with bac-PrVgDt or bac-BHV1gDt at a
ultiplicity of infection (m.o.i.) of 4, and the cells were
emoved by centrifugation at 48–72 h postinfection. The
upernatant was filtered and the buffer was exchanged
ith phosphate-buffered saline (PBS, 20 mM sodium
hosphate buffer containing 0.15 M NaCl) either by dial-
sis (12 to 14 kDa molecular mass cutoff) or by tangential
low filtration (10 kDa molecular mass cutoff membrane;
illipore, Bedford, MA). The supernatant was then incu-
ated with nickel-nitriloacetic acid resin (Qiagen) over-
ight on a rotary shaker at 4°C. The resin was pelleted,
esuspended in PBS, and transferred to a column. The
roteins were eluted using increasing concentrations of
midazole buffer (0.01 to 0.25 M) in 20 mM sodium phos-
hate buffer (pH 7.5) containing 0.5 M NaCl. The bulk of
urified PrV gDt and BHV-1 gDt eluted in 100–250 mM
midazole. These elution fractions were dialyzed (PBS)
nd concentrated using a 10 kDa molecular mass cen-
rifugal membrane (Millipore). Total protein concentra-
ions were determined by a Coomassie assay (Pierce,
ockford, IL). The yield of purified protein was 0.5 to 5
g/L of supernatant.
roduction and purification of HSV-1 gDt, HSV-1 gCt,
nd soluble receptors
The procedures for production and purification of
SV-1 gDt, HSV-1 gCt, HveAt, HveBt, HveCt, and
veC(143t) were described previously (Krummenacher et
l., 1998, 1999; Sisk et al., 1994; Tal-Singer et al., 1995;
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15AFFINITIES OF gD HOMOLOGS FOR HveC (NECTIN-1)Warner et al., 1998; Whitbeck et al., 1997). For clarity, the
runcated forms HSV gD-1(306t), HSV gC-1(457t),
veA(200t), HveB(361t), and HveC(346t) are referred to
ere as HSV-1 gDt, HSV-1 gCt, HveAt, HveBt, and HveCt,
espectively. These proteins were truncated just prior to
he transmembrane region and tagged with six-His tails.
veC(143t) was truncated C-terminal to the V domain of
veC and tagged with a six-His tail. The molecular
eights of HSV-1 gDt and HSV-1 gCt are 37.2 and 58 kDa,
espectively.
DS–PAGE analysis
Purified glycoproteins were separated by sodium do-
ecyl sulfate–polyacrylamide gel electrophoresis (SDS–
AGE) under reducing conditions in precast Tris–glycine
els (Novex, San Diego, CA). Following SDS–PAGE, the
roteins were either stained with silver nitrate (Pharma-
ia Laboratories, Piscataway, NJ) or transferred to nitro-
ellulose and incubated in PBS containing 5% nonfat dry
ilk and 0.2% Tween 20 (blocking solution). Blots were
eacted with various MAbs and incubated with second-
ry antibody (goat anti-mouse or goat anti-rabbit) cou-
led to horseradish peroxidase (HRP). Blots were
ashed and visualized by exposure to film after the
ddition of chemilumenescent substrate (ECL; Amer-
ham, Arlington Heights, IL).
ntigenic analysis by dot blot
PrV gDt, BHV-1 gDt, and BSA were denatured by boil-
ng in SDS and b-mercaptoethanol. Equivalent amounts
f denatured and native protein were immobilized onto
itrocellulose using a dot-blot apparatus. Blots were in-
ubated in blocking solution and reacted overnight at
°C with MAbs at a dilution of 1:500. Blots were then
isualized as described above. MAbs were classified as
equiring native conformation for maximal reactivity if
hey reacted with native protein better than with dena-
ured protein.
mmunoprecipitations
Samples (300 ng) of HSV-1 gDt, PrV gDt, or BHV-1 gDt
ere incubated on ice with 1, 2, 4, or 8 mL of MAb ascites
fluid in 50 mL binding buffer (10 mM Tris, pH 8.0; 100 mM
NaCl; 0.1% NP-40; 0.05% BSA; 0.05% chicken egg albu-
min). HSV-1 gDt was incubated with MAb DL2 or DL6.
PrV gDt was incubated with MAb 6D8MB4 or S4B1.1C11.
BHV-1 gDt was incubated with MAb 1B8-F11 or 2H6-C2.
As a negative control, each gDt was also incubated with
MAb CW2. After 1 h, 50 mL of protein A–agarose (50%)
was added to each mixture on ice. After another hour, the
agarose was washed three times with high-salt buffer
(10 mM Tris, pH 8.0; 500 mM NaCl; 0.1% NP-40; 0.05%
BSA; 0.05% chicken egg albumin) and then boiled in 23
SDS sample buffer (Nicola et al., 1998). Following SDS–PAGE, Western blots were probed with rabbit antisera R7
for HSV-1 gDt, R170 for PrV gDt, or EnvA for BHV-1 gDt.
Mass spectroscopy
Matrix-assisted laser desorption ionization mass
spectrometry was performed in the linear mode on a
Micromass TofSpec 2E time-of-flight mass spectrometer
(1.0 m flight tube; Micromass, Beverly, MA) outfitted with
an N2 (337 nm, 4 ns pulse) laser. Samples were diluted
in matrices, using a-cyano-4-hydroxycinnamic acid as
the matrix.
Glycosidase digestions
Purified PrV gDt, BHV-1 gDt, or HSV-1 gDt (1 mg) was
denatured and treated with either 0.8 mU endoglycosi-
dase H (Boehringer Mannheim, Indianapolis, IN) or 32
mU endoglycosidase F (Boehringer Mannheim) for 5 h at
37°C. The digestion products were analyzed by Western
blot using an anti-tetra-His MAb.
Enzyme-linked immunosorbent assay (ELISA)
ELISA experiments were performed essentially as de-
scribed previously (Whitbeck et al., 1997). Microtiter
plates were coated for 2 h with 50 mL of purified soluble
eceptor in PBS at a concentration of 4 mg/mL for HveAt
or 10 mg/mL for HveBt or HveCt. Plates were washed
with 0.1% Tween 20 in PBS and nonspecific binding was
blocked by incubation with blocking solution. Serial di-
lutions of gDt (or other proteins) prepared in blocking
solution were added for 2 h. The plates were washed
and either MAbs (diluted 1:500 in blocking solution) or
rabbit sera (diluted 1:1000) were added for 1 h to detect
bound gDt. The plates were washed and HRP-conju-
gated goat anti-mouse or anti-rabbit antibodies were
added for 30 min, washed again, and then rinsed with 20
mM citrate buffer (pH 4.5). ABTS peroxidase substrate
(Moss, Inc., Pasadena, MD) was added and the absor-
bance at 405 nm was detected with a microtiter plate
reader. Signals from identically treated wells that lacked
receptor were subtracted from the results to account for
background.
Optical biosensor analysis
Surface plasmon resonance experiments (Karlsson et
al., 1991; Myszka, 1999) were carried out essentially as
described previously (Krummenacher et al., 1999; Rux et
al., 1998; Whitbeck et al., 1999; Willis et al., 1998b) on a
BIAcore X optical biosensor (BIAcore AB, Uppsala, Swe-
den) at 25°C. The running buffer was HBS-EP (BIAcore)
containing 0.005% Tween 20. Flow cell 2 (Fc2) of a CM5
sensor chip was activated, HveCt was coupled via pri-
mary amines, and the flow cell surface was blocked.
Between 1510 and 1750 resonance units (RU) of HveCt
were immobilized for each chip used. Flow cell 1 (Fc1)
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16 CONNOLLY ET AL.was activated and blocked without the addition of pro-
tein. To characterize the binding of proteins to HveCt, the
flow path included both flow cells, the flow rate was 50
mL/min, and the data collection rate was 5 Hz. Proteins
were serially diluted in HBS-EP. Binding was allowed for
2 min and the wash was delayed 2 min to allow for a
smooth dissociation curve. The chip surface was regen-
erated with short pulses of Na2CO3 (pH 9.5–10.5) until the
esponse signal on both flow cells returned to baseline.
ensorgrams were corrected for nonspecific binding by
ubtracting the signal achieved on Fc1 from that on Fc2.
he signal obtained when buffer alone was injected was
hen subtracted from the total signal. The sensorgrams
ere analyzed using BIAEvaluation software, version 3.0.
odel curve fitting was performed using global fitting
ith a 1:1 Langmuir binding model with drifting baseline.
his is the simplest model for the interaction between a
eceptor and ligand. It follows the equation A 1 Bu AB.
he rate of association (kon) is measured from the for-
ard reaction and the rate of dissociation (koff) measured
rom the reverse reaction: koff/kon 5 KD. We discounted
the effects of mass transport by running samples at
different flow rates and ensuring signals were not flow-
rate dependent. For BHV-1 gDt, a maximum koff was
estimated using the equation ln(R0/Rn) 5 koff(tn 2 t0),
where R0 is the response at time zero (t0) of dissociation
and Rn is the response at time n (tn). The reported
maximum koff is equal to the slope of a linear fit to the
nitial second of dissociation of 16 mM BHV gDt.
irus entry inhibition assay
PK15, M3A, or CHO-IEb8 cells (as negative control)
were plated in 96-well plates and grown to confluence
overnight. Cells were chilled to 4°C and the medium was
replaced with DMEM–5% FCS containing various con-
centrations of PrV gDt, HSV-1 gDt, or BSA. After rocking
for 90 min at 4°C, HSV-1 hrR3 (m.o.i. 5 0.5) or PrV BeBlu
(m.o.i. 5 5) was added, incubated for 90 min at 4°C, and
then shifted to 37°C. After 5 h, the cells were washed
with PBS and lysed in DMEM containing 0.5% NP-40.
b-Galactosidase activity was measured by addition of
cell lysate to substrate (CPRG; Boehringer Mannheim).
Absorbance at 570 nm at multiple time points was de-
tected using a microtiter plate reader, the slopes were
recorded, and the results were plotted as percentages of
controls in which no protein was added.
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